First published 9/29/2026, 10:03:15 PM · Last updated 9/29/2026, 10:03:15 PM

3D Electron Diffraction Elucidates the Structure of a 1,3,5-Triazin-2,4-dione Cinnamamide Covalent Inhibitor of SARS-CoV-2 3CLpro

A journal article published by the American Chemical Society reports use of 3D electron diffraction to determine the structure of a 1,3,5-triazin-2,4-dione cinnamamide covalent inhibitor that targets the SARS-CoV-2 3CLpro protease. The source record supplied to Planet Briefing includes only the article title, publisher, and publication date without further experimental or outcome details.

Categories: science-and-space, public-health, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Structural determination of a SARS-CoV-2 3CLpro inhibitor may aid scientific efforts against the virus.

Sources

3D Electron Diffraction Elucidates the Structure of a 1,3,5-Triazin-2,4-dione Cinnamamide Covalent Inhibitor of SARS-CoV-2 3CLpro

Report an issue